Meeting
2018 Genitourinary Cancers Symposium
Impact of 2012 USPSTF prostate cancer screening recommendations on prostate cancer detection and presentation at Kaiser Permanente Northern California (KPNC).
Authors
Joe Presti Jr.
Kaiser Permanente, Oakland, CA
Joe Presti Jr., Brandon Horton , Stacey Alexeeff , Stephanie Prausnitz , Andy Avins
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 37)
DOI
10.1200/JCO.2018.36.6_suppl.37
Abstract #
37
Poster Bd #
C1
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Impact of COVID-19 on the incidence of prostate cancer among White and Black Veterans.
First Author: Kyung Min Lee
Poster
2023 ASCO Genitourinary Cancers Symposium
The profile study: Prostate cancer screening in men of Black African and African Caribbean ancestry—Early results.
First Author: Netty Kinsella
Poster
2022 ASCO Annual Meeting
Longitudinal screening for depression and anxiety in prostate cancer (PC) and association with disease and treatment factors.
First Author: Risa Liang Wong
Poster
2022 ASCO Genitourinary Cancers Symposium
The BARCODE1 study in primary care: Early results targeting men with increased genetic risk of developing prostate cancer—Examining the interim data from a community-based screening program using polygenic risk score to target screening.
First Author: Jana Kathlyn McHugh